This is actually the same interview from two weeks ago (below), but a good overview. The next few weeks should be very interesting, and then more data to come in Jan and Feb. Here's the general timeline given from the Nov 14 conference call. The key (imo) will be the 94 day data -
Dec ------------ Sustained Clinical Cure data
Dec or Jan --- Extended Clinical Cure data up to 94 days
Jan or Feb --- Impact on Microbiome data
March --------- End of Phase 2 meeting with FDA
Summary - https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173224909
---
Recent ACXP News
- Acurx Announces New Bile Acid and Microbiome Analyses from Ph2b Trial of Ibezapolstat in CDI Patients Presented at IDWeek Scientific Conference • PR Newswire (US) • 10/21/2024 11:00:00 AM
- Acurx Pharmaceuticals Announces Participation at The Spartan Capital Investor Conference to Showcase Growth Companies and Foster High-Level Investor Engagement • PR Newswire (US) • 10/17/2024 12:00:00 PM
- Acurx Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 13, 2024 • PR Newswire (US) • 10/16/2024 12:00:00 PM
- Acurx Announces Additional Ibezapolstat Ph2b Results in CDI as well as Anthrax (B. anthracis) Susceptibility to ACX-375 Analogues • PR Newswire (US) • 09/26/2024 11:00:00 AM
- Acurx Announces Results of Its Pioneering Research with Ibezapolstat in Collaboration with Leiden University Medical Center at the Premier International C. difficile Symposium • PR Newswire (US) • 09/24/2024 11:00:00 AM
- New to The Street Announces its Five Corporate Interviews, Airing Episode 591 on the Fox Business Network, Tonight Monday, August 26, 2024, at 10:30 PM PT • GlobeNewswire Inc. • 08/26/2024 01:15:00 PM
- ACURX PHARMACEUTICALS ANNOUNCES PARTICIPATION AT THE H.C. Wainwright 26th Annual Global Investment Conference • PR Newswire (US) • 08/26/2024 11:00:00 AM
- New to The Street Announces Episode 590, Five Corporate Interviews, Airing on the Fox Business Network, Tonight Monday, August 19, 2024, at 10:30 PM PT • GlobeNewswire Inc. • 08/19/2024 01:20:00 PM
- New to The Street TV Announces Episode 583, Five Riveting Business Guest Interviews, Airs on Bloomberg TV as Sponsored Programming, Saturday, August 10, 2024, at 6:30 PM ET • GlobeNewswire Inc. • 08/09/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 11:13:16 AM
- Acurx Pharmaceuticals, Inc. Reports Second Quarter 2024 Results and Provides Business Update • PR Newswire (US) • 08/09/2024 11:01:00 AM
- USPTO Grants Acurx Pharmaceuticals New Patent for Ibezapolstat to Treat CDI While Reducing Recurrence of Infection and Improving Health of the Gut Microbiome • PR Newswire (US) • 07/17/2024 11:00:00 AM
- Acurx Pharmaceuticals, Inc. to Discuss Second Quarter 2024 Financial Results on August 9, 2024 Conference Call and Provide Business Update • PR Newswire (US) • 07/16/2024 11:00:00 AM
- Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results for CDI at Scientific Conference • PR Newswire (US) • 07/15/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 08:14:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 08:11:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2024 08:14:40 PM
- New to The Street Announces Episode 576, Four Business Guest Interviews, Airs on Bloomberg TV as Sponsored Programming, Tonight, Thursday, June 6, 2024, at 9:30 PM PT • GlobeNewswire Inc. • 06/06/2024 01:30:00 PM
- Acurx Announces Successful FDA End-of-Phase 2 Meeting and Phase 3 Readiness for Ibezapolstat in the Treatment of C. difficile Infection • PR Newswire (US) • 05/15/2024 01:00:00 PM
- U.S. Index Futures Flat Ahead of April CPI Data Release, Oil Prices Drop • IH Market News • 05/15/2024 11:50:05 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 11:13:05 AM
- Acurx Pharmaceuticals, Inc. Reports First Quarter 2024 Results and Provides Business Update • PR Newswire (US) • 05/15/2024 11:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 08:05:29 PM
- Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results at ESCMID Global 2024 Scientific Conference • PR Newswire (US) • 05/02/2024 11:00:00 AM
- Acurx Pharmaceuticals Announces Presentation of Ibezapolostat Phase 2 Clinical Trial Results at upcoming ESCMID 2024 Scientific Conference • PR Newswire (US) • 04/25/2024 02:12:00 PM
FEATURED North Bay Resources Announces Federal (MSHA) Approval of Mt. Vernon Gold Mine Operational Plan and Commencement of Production, Sierra County, California • Oct 21, 2024 9:00 AM
Hydromer, Inc. Announces the Restructuring and Formation of World-Class Research and Development Division to Drive Innovation and New Product Development • HYDI • Oct 21, 2024 9:00 AM
SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering • SNWV • Oct 18, 2024 9:31 AM
Vocodia Addresses Recent Stock Price Movement and Future Strategic Partnerships • VHAI • Oct 18, 2024 9:00 AM
Mass Megawatts Announces the Start of an Online Discount Solar Energy Equipment Business with Revenue Recognized for the First Time Since Year 2010 in this Fiscal Quarter • MMMW • Oct 18, 2024 7:32 AM
Unitronix Corp Advances DeFi Innovation with Tokenized Real-World Assets Integration • UTRX • Oct 17, 2024 7:38 AM